The Cannabinoid Receptor Agonist WIN 55,212-2 Reduces D2, but Not D1, Dopamine Receptor-Mediated Alleviation of Akinesia in the Reserpine-Treated Rat Model of Parkinson's Disease
- 1 November 1997
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 148 (1) , 265-270
- https://doi.org/10.1006/exnr.1997.6645
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Modulation of Neurotransmission by Cannabinoids in the Basal GangliaEuropean Journal of Neuroscience, 1997
- The cannabinoid agonists WIN 55,212-2 and CP 55,940 attenuate rotational behavior induced by a dopamine D1 but not a D2 agonist in rats with unilateral lesions of the nigrostriatal pathwayBrain Research, 1995
- Neuronal localization of cannabinoid receptors in the basal ganglia of the ratBrain Research, 1991
- Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primateMovement Disorders, 1991
- Evidence for interconnections between the two segments of the globus pallidus in primates: a PHA-L anterograde tracing studyBrain Research, 1990
- Cannabinoid receptor localization in brain.Proceedings of the National Academy of Sciences, 1990
- The functional anatomy of basal ganglia disordersTrends in Neurosciences, 1989
- Pallidal inputs to subthalamus: Intracellular analysisBrain Research, 1983
- Effect of cannabinoids on neurotransmitter uptake, atpase activity and morphology of mouse brain synaptosomesBiochemical Pharmacology, 1977
- The effect of Δ9-tetrahydrocannabinol on the uptake and release of 14C-dopamine from crude striatal synaptosomal preparationsNeuropharmacology, 1974